{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:34:12Z","timestamp":1791387252353,"version":"4.3.3"},"reference-count":74,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1001\/jamaneurol.2019.0591","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T13:11:58Z","timestamp":1554729118000},"page":"855","source":"Crossref","is-referenced-by-count":121,"title":["Tailoring the Approach to Embolic Stroke of Undetermined Source"],"prefix":"10.1001","volume":"76","author":[{"given":"Hooman","family":"Kamel","sequence":"first","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York"},{"name":"Associate Editor, JAMA Neurology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Merkler","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Iadecola","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Gupta","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York"},{"name":"Department of Radiology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak B.","family":"Navi","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute and Department of Neurology, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"nrv190002r1","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","article-title":"Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.","volume":"1","author":"Krishnamurthi","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"4","key":"nrv190002r2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update.","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke"},{"issue":"8","key":"nrv190002r3","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/STROKEAHA.109.575373","article-title":"Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study.","volume":"41","author":"Marnane","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"nrv190002r4","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct.","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"23","key":"nrv190002r5","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"nrv190002r7","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1474-4422(15)00132-5","article-title":"Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study.","volume":"14","author":"Li","year":"2015","journal-title":"Lancet Neurol"},{"issue":"10","key":"nrv190002r8","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1056\/NEJMc1809065","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"379","author":"Harloff","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"nrv190002r9","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1056\/NEJMc1809065","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"379","author":"Girgis","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"nrv190002r10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/STROKEAHA.109.571455","article-title":"Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events.","volume":"41","author":"Ziegler","year":"2010","journal-title":"Stroke"},{"issue":"4","key":"nrv190002r11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(15)70027-X","article-title":"Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.","volume":"14","author":"Sposato","year":"2015","journal-title":"Lancet Neurol"},{"issue":"26","key":"nrv190002r12","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke.","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"nrv190002r13","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation.","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"issue":"7","key":"nrv190002r14","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"38","key":"nrv190002r15","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"8","key":"nrv190002r16","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1212\/WNL.0000000000000145","article-title":"Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"82","author":"Culebras","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"nrv190002r17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1161\/CIRCRESAHA.114.303772","article-title":"Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy.","volume":"114","author":"Chen","year":"2014","journal-title":"Circ Res"},{"issue":"10","key":"nrv190002r18","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/STROKEAHA.118.022826","article-title":"Incidence of atrial fibrillation in patients with recent ischemic stroke versus matched controls.","volume":"49","author":"Witsch","year":"2018","journal-title":"Stroke"},{"key":"nrv190002r19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ahj.2017.04.008","article-title":"Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.","volume":"189","author":"Lopes","year":"2017","journal-title":"Am Heart J"},{"key":"nrv190002r20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ahj.2017.04.015","article-title":"Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes (NOAH-AFNET 6) trial.","volume":"190","author":"Kirchhof","year":"2017","journal-title":"Am Heart J"},{"issue":"2","key":"nrv190002r21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke.","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"nrv190002r22","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","article-title":"Temporal relationship between subclinical atrial fibrillation and embolic events.","volume":"129","author":"Brambatti","year":"2014","journal-title":"Circulation"},{"issue":"26","key":"nrv190002r23","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/eurheartj\/ehv115","article-title":"Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices.","volume":"36","author":"Martin","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"nrv190002r24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jacep.2017.10.010","article-title":"Multimodal examination of atrial fibrillation substrate: correlation of left atrial bipolar voltage using multi-electrode fast automated mapping, point-by-point mapping, and magnetic resonance image intensity ratio.","volume":"4","author":"Zghaib","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"nrv190002r25","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.","volume":"114","author":"Heijman","year":"2014","journal-title":"Circ Res"},{"issue":"9","key":"nrv190002r26","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1161\/STROKEAHA.114.006364","article-title":"P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis.","volume":"45","author":"Kamel","year":"2014","journal-title":"Stroke"},{"issue":"4","key":"nrv190002r27","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.115.016795","article-title":"Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate.","volume":"132","author":"Goldberger","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"nrv190002r28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jacc.2015.04.069","article-title":"Premature atrial contractions: a wolf in sheep\u2019s clothing?","volume":"66","author":"Marcus","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"nrv190002r29","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.jacc.2015.03.557","article-title":"Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: mechanistic links and clinical inferences.","volume":"65","author":"Hirsh","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"nrv190002r30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke: time for a new model.","volume":"47","author":"Kamel","year":"2016","journal-title":"Stroke"},{"issue":"10","key":"nrv190002r31","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1161\/01.STR.30.10.2019","article-title":"Left atrial size and the risk of ischemic stroke in an ethnically mixed population.","volume":"30","author":"Di Tullio","year":"1999","journal-title":"Stroke"},{"issue":"4","key":"nrv190002r32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/STROKEAHA.111.000173","article-title":"Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study.","volume":"44","author":"Folsom","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"nrv190002r33","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1161\/STROKEAHA.112.675942","article-title":"Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy.","volume":"44","author":"Longstreth","year":"2013","journal-title":"Stroke"},{"issue":"5","key":"nrv190002r34","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/ana.v78.5","article-title":"Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study.","volume":"78","author":"Kamel","year":"2015","journal-title":"Ann Neurol"},{"issue":"11","key":"nrv190002r35","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.1161\/STROKEAHA.115.009989","article-title":"Electrocardiographic left atrial abnormality and risk of stroke: Northern Manhattan study.","volume":"46","author":"Kamel","year":"2015","journal-title":"Stroke"},{"issue":"20","key":"nrv190002r36","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa011258","article-title":"A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.","volume":"345","author":"Mohr","year":"2001","journal-title":"N Engl J Med"},{"key":"nrv190002r37","article-title":"Recurrent stroke with rivaroxaban compared with aspirin in the NAVIGATE ESUS trial according to predictors of atrial fibrillation","author":"Healey","journal-title":"JAMA Neurol"},{"issue":"2","key":"nrv190002r38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1747493018799981","article-title":"The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: Rationale and methods.","volume":"14","author":"Kamel","year":"2019","journal-title":"Int J Stroke"},{"issue":"1","key":"nrv190002r39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial, TOAST: Trial of Org 10172 in Acute Stroke Treatment.","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"22","key":"nrv190002r40","doi-asserted-by":"publisher","first-page":"e010782","DOI":"10.1161\/JAHA.118.010782","article-title":"Duration of heightened ischemic stroke risk after acute myocardial infarction.","volume":"7","author":"Merkler","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"nrv190002r41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.7326\/0003-4819-122-2-199501150-00003","article-title":"Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris: the Reykjavik study.","volume":"122","author":"Sigurdsson","year":"1995","journal-title":"Ann Intern Med"},{"issue":"23","key":"nrv190002r42","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.105.570648","article-title":"Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.","volume":"113","author":"Kwong","year":"2006","journal-title":"Circulation"},{"issue":"9","key":"nrv190002r43","doi-asserted-by":"publisher","first-page":"e005905","DOI":"10.1161\/JAHA.117.005905","article-title":"Association between troponin levels and embolic stroke of undetermined source.","volume":"6","author":"Merkler","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"nrv190002r44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1161\/STROKEAHA.117.019395","article-title":"Early elevated troponin levels after ischemic stroke suggests a cardioembolic source.","volume":"49","author":"Yaghi","year":"2018","journal-title":"Stroke"},{"issue":"14","key":"nrv190002r45","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without aspirin in stable cardiovascular disease.","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"nrv190002r46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.018","article-title":"Risk of stroke in patients with patent foramen ovale: an updated meta-analysis of observational studies.","volume":"23","author":"Ma","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"nrv190002r47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000352050","article-title":"The ASCOD phenotyping of ischemic stroke (updated ASCO phenotyping).","volume":"36","author":"Amarenco","year":"2013","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"nrv190002r48","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1161\/STROKEAHA.107.490896","article-title":"A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System.","volume":"38","author":"Ay","year":"2007","journal-title":"Stroke"},{"issue":"18","key":"nrv190002r49","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1093\/eurheartj\/ehy121","article-title":"Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials.","volume":"39","author":"Ahmad","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"nrv190002r50","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S1474-4422(18)30319-3","article-title":"Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.","volume":"17","author":"Kasner","year":"2018","journal-title":"Lancet Neurol"},{"issue":"8","key":"nrv190002r51","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1182\/blood-2018-06-860874","article-title":"Arterial thromboembolic events preceding the diagnosis of cancer in older persons.","volume":"133","author":"Navi","year":"2019","journal-title":"Blood"},{"issue":"5","key":"nrv190002r52","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ana.v83.5","article-title":"Ischemic stroke in cancer patients: a review of an underappreciated pathology.","volume":"83","author":"Navi","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"nrv190002r53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","article-title":"Association between incident cancer and subsequent stroke.","volume":"77","author":"Navi","year":"2015","journal-title":"Ann Neurol"},{"issue":"8","key":"nrv190002r54","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jacc.2017.06.047","article-title":"Risk of arterial thromboembolism in patients with cancer.","volume":"70","author":"Navi","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"nrv190002r55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/WNL.0000000000000539","article-title":"Recurrent thromboembolic events after ischemic stroke in patients with cancer.","volume":"83","author":"Navi","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"nrv190002r56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1001\/jamaneurol.2017.4211","article-title":"Enoxaparin vs aspirin in patients with cancer and ischemic stroke: the TEACH pilot randomized clinical trial.","volume":"75","author":"Navi","year":"2018","journal-title":"JAMA Neurol"},{"issue":"4","key":"nrv190002r57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jcmg.2012.01.012","article-title":"Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke.","volume":"5","author":"Freilinger","year":"2012","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"nrv190002r58","doi-asserted-by":"crossref","first-page":"e002012","DOI":"10.1161\/JAHA.115.002012","article-title":"Magnetic resonance angiography detection of abnormal carotid artery plaque in patients with cryptogenic stroke.","volume":"4","author":"Gupta","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"nrv190002r59","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/j.jcmg.2015.12.004","article-title":"Association between nonstenosing carotid artery plaque on MR angiography and acute ischemic stroke.","volume":"9","author":"Gupta","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"nrv190002r60","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0000000000002978","article-title":"Nonstenotic carotid plaque on CT angiography in patients with cryptogenic stroke.","volume":"87","author":"Coutinho","year":"2016","journal-title":"Neurology"},{"issue":"22","key":"nrv190002r61","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJM199412013312202","article-title":"Atherosclerotic disease of the aortic arch and the risk of ischemic stroke.","volume":"331","author":"Amarenco","year":"1994","journal-title":"N Engl J Med"},{"issue":"7","key":"nrv190002r62","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/ijs.12509","article-title":"Global survey of the diagnostic evaluation and management of cryptogenic ischemic stroke.","volume":"10","author":"Giruparajah","year":"2015","journal-title":"Int J Stroke"},{"issue":"13","key":"nrv190002r63","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa043033","article-title":"Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis.","volume":"352","author":"Chimowitz","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"nrv190002r64","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/STROKEAHA.113.004251","article-title":"Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques.","volume":"45","author":"Amarenco","year":"2014","journal-title":"Stroke"},{"key":"nrv190002r65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/ijs.12546","article-title":"Impact of initial symptom for accurate diagnosis of vertebral artery dissection.","volume":"10","author":"Fukuhara","year":"2015","journal-title":"Int J Stroke"},{"issue":"4","key":"nrv190002r66","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1474-4422(15)70018-9","article-title":"Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial.","volume":"14","author":"Markus","year":"2015","journal-title":"Lancet Neurol"},{"key":"nrv190002r67","article-title":"Antiplatelet therapy vs anticoagulation therapy in cervical artery dissection: the Cervical Artery Dissection in Stroke Study (CADISS) randomized clinical trial final results","author":"Markus","journal-title":"JAMA Neurol"},{"issue":"19","key":"nrv190002r68","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1212\/WNL.0000000000001409","article-title":"Prevalence and distribution of VZV in temporal arteries of patients with giant cell arteritis.","volume":"84","author":"Gilden","year":"2015","journal-title":"Neurology"},{"issue":"2","key":"nrv190002r69","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/1941874413502796","article-title":"Amyloid \u00df-related central nervous system angiitis presenting with an isolated seizure.","volume":"4","author":"Ishii","year":"2014","journal-title":"Neurohospitalist"},{"issue":"4","key":"nrv190002r70","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1001\/jamacardio.2016.0582","article-title":"Association of atrial fibrillation and cancer.","volume":"1","author":"Rahman","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"10","key":"nrv190002r71","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: atrial fibrillation in cancer.","volume":"63","author":"Farmakis","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"nrv190002r72","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.arcmed.2017.03.005","article-title":"Atherosclerosis and cancer; a resemblance with far-reaching implications.","volume":"48","author":"Tapia-Vieyra","year":"2017","journal-title":"Arch Med Res"},{"issue":"13","key":"nrv190002r73","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/jnci\/djp147","article-title":"Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.","volume":"101","author":"De Bruin","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"nrv190002r74","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1747493016681019","article-title":"Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design.","volume":"12","author":"Geisler","year":"2017","journal-title":"Int J Stroke"},{"key":"nrv190002r6","unstructured":"DienerHC, SaccoRL, EastonJD, . Dabigatran versus acetylsalicylic acid for stroke prevention in patients with embolic stroke of undetermined source. https:\/\/cmoffice.kenes.com\/cmsearchableprogrammeV15\/conferencemanager\/programme\/personid\/anonymous\/WSC18\/normal\/b833d15f547f3cf698a5e922754684fa334885ed#!abstractdetails\/0000087910. Published October 20, 2018. Accessed February 27, 2019."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/7\/855\/17684709\/jamaneurology_kamel_2019_rv_190002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T11:00:54Z","timestamp":1562583654000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2019.0591"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2019.0591","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}